Search Results

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care (POC) diagnostics, today announced the appointment of Christopher R. Hetterly as Chief Financial Officer (CFO).

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced that it has entered into a distribution agreement with Gepa Srl (“Gepa”), a distributor and supplier of diagnostic products in Italy.

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”) , a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has initiated a clinical validation study with Hospital Clinico San Carlos (“HCSC”) in Madrid, Spain to evaluate the performance of the Nanomix eLab.

Nanomix Corporation today announced a new distribution agreement with Diaclinic SpA (“Diaclinic”), a medical distributor headquartered in Santiago, Chile.

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced the appointment of Tadd S. Lazarus, M.D., to the Board of Directors as an independent director.

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has received the EU Quality Management System Certificate under the new In Vitro Diagnostic Medical Devices Regulation (IVDR) for its eLab analyzer, part of the Nanomix eLab® system.

Nanomix Corporation, a leader in the development of mobile, affordable, point-of-care diagnostics, announced that it has entered into an exclusive distribution agreement with Woodley Equipment Company, Ltd., a global veterinary distributor.

Nanomix Corporation today announced that it has entered into a multi-region distribution agreement with Mast Group Limited (“Mast”), an independent world class manufacturer and supplier of diagnostic products for clinical, industrial and veterinary testing.

Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced that it has received ISO 13485:2016 certification for its new facility in San Leandro, California.

Nanomix Corporation today announced the completion of its name change from Nanomix, Inc. to Nanomix Corporation and its ticker symbol from “BTHE” to “NNMX”.